Senate Democrats Introduce Bill to Allow Government to Block Drug Price Rises
WASHINGTON (Reuters)—Four Democratic U.S. senators introduced a bill on Thursday that would allow the government to block drug price increases that it decides are unjustified. The bill sponsored by Senators Richard Blumenthal, Kamala Harris, Amy Klobuchar and Jeff Merkley, all Democrats, would allow the Department of Health and Human Services to prohibit drug price increases... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - December 15, 2018 Category: Rheumatology Authors: Reuters Staff Tags: Legislation & Advocacy drug price legislation Jeff Merkley Kamala Harris prohibit drug price increases Richard Blumenthal Sen. Amy Klobuchar Source Type: research

Big Data Drives New Research
Big data can benefit rheumatology research. But according to experts at the 2018 ACR/ARHP Annual Meeting, the data must first be accessible, interoperable and shareable... (Source: The Rheumatologist)
Source: The Rheumatologist - December 12, 2018 Category: Rheumatology Authors: Susan Bernstein Tags: Technology big data electronic health record (EHR) Research Source Type: research

ACR Delegates Move Rheumatology Concerns Forward at AMA
At the AMA’s recent House of Delegates Interim Meeting, the ACR’s delegation was able to incorporate rheumatology concerns into official AMA policy, in addition to leading a major multi-specialty resolution on the CMS-proposed move to consolidate and cut evaluation and management (E/M) services. The ACR is able to make this progress because members of the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - December 10, 2018 Category: Rheumatology Authors: Gary Bryant Tags: Meeting Reports Professional Topics AMA House of Delegates (HOD) American Gastroenterology Association (AGA) American Society of Clinical Oncology (ASCO) evaluation and management (E/M) services House of Delegates interim meeting Source Type: research

Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector
In a study, RA patients taking upadactinib monotherapy experienced less pain and morning joint stiffness than methotrexate-treated patients... (Source: The Rheumatologist)
Source: The Rheumatologist - December 10, 2018 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates ACTPen autoinjector Methotrexate monotherapy Rheumatoid Arthritis (RA) tocilizumab upadacitinib Source Type: research

MUC5B Promoter Variant Associated with RA with Interstitial Lung Disease
New research has linked the risk of developing interstitial lung disease in rheumatoid arthritis patients with the promoter variant in MUC5B, which may also contribute to the development of idiopathic pulmonary fibrosis and an unsual interstitial pneumonia seen by high-resolution CT scan... (Source: The Rheumatologist)
Source: The Rheumatologist - December 10, 2018 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Rheumatoid Arthritis ILD Interstitial Lung Disease MUC5B Rheumatoid Arthritis (RA) Source Type: research

Suleman Bhana, MD, FACR, Brings a Fresh Perspective as CMC Chair
Chairing the ACR’s Communications and Marketing Committee (CMC) can be a monumental task: The CMC is responsible for both internal and external communications to a variety of people, including rheumatology providers, patients, lawmakers, the pharmaceutical industry and others. But the CMC’s newest chair, Suleman Bhana, MD, FACR, is up for the job. The Rheumatologist recently... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - December 6, 2018 Category: Rheumatology Authors: Kelly Tyrrell Tags: Profiles Communications and Marketing Committee (CMC) Suleman Bhana Source Type: research

Committee on Rheumatologic Care Helps Establish Principles & Position Statements
The ACR’s Committee on Rheumatologic Care (CORC) has been busy on many fronts, including establishing new position statements for the College, introducing new practice perspectives and engaging multiple stakeholders in actions to protect and enhance rheumatology practice, such as with payers. “CORC ensures the rheumatology voice is heard in all of the most critical venues,”... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - December 6, 2018 Category: Rheumatology Authors: Carina Stanton Tags: Legislation & Advocacy ACR Principles on Prescription Drug Prices and Access to Treatment Committee on Rheumatologic Care (CORC) new position statements standing member position Source Type: research

Swamy Venuturupalli, MD: Improving Access to Education
Early in his medical career, Swamy Venuturupalli, MD, sought clinical direction toward a specialty that allowed him to look at the patient in multiple domains, and he found a perfect fit in rheumatology. His passion for understanding the many aspects of rheumatic disease led Dr. Venuturupalli to become actively involved in the Rheumatology Fellowship Program... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - December 6, 2018 Category: Rheumatology Authors: Carina Stanton Tags: Profiles Committee on Education Swamy Venuturupalli Source Type: research

How Decentralized Technology May Revolutionize Data in Healthcare
Rheumatologists may benefit from the decentralized technology that makes cryptocurrency possible: blockchain. According to Anh L. Ngo, MD, MBA, using blockchain in healthcare may increase payment and purchasing efficiency and revolutionize EHR management... (Source: The Rheumatologist)
Source: The Rheumatologist - December 5, 2018 Category: Rheumatology Authors: Susan Bernstein Tags: Technology bitcoin blockchain data data management electronic health record (EHR) information technology Source Type: research

Low Muscle Density & Physical Function in Patients with RA
Low muscle density due to the accumulation of intramuscular fat has been observed in RA patients and is associated with higher disease activity. New research sought to understand the relationship between muscle density, physical function and strength independent of body composition, including such factors as total and visceral adiposity. The results: Compared with healthy controls, low muscle density in RA patients was associated with low muscle mass, excess adiposity and greater disability... (Source: The Rheumatologist)
Source: The Rheumatologist - December 4, 2018 Category: Rheumatology Authors: Arthritis Care & Research Tags: Conditions Rheumatoid Arthritis Arthritis Care & Research function muscle muscle density physical activity Rheumatoid Arthritis (RA) Source Type: research

FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
The FDA has approved halobetasol propionate lotion as a topical treatment for plaque psoriasis... (Source: The Rheumatologist)
Source: The Rheumatologist - December 3, 2018 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates dermatitis dupilumab FDA halobetasol propionate lotion plaque psoriasis U.S. Food and Drug Administration (FDA) Source Type: research

Patients with Psoriatic Arthritis at Increased Risk for Type 2 Diabetes
New research shows that patients with psoriatic arthritis (PsA) have a greater risk for developing type 2 diabetes than patients with psoriasis alone or the general population. Researchers also found that PsA and psoriasis patients have a similar rate of increased risk for cardiovascular disease... (Source: The Rheumatologist)
Source: The Rheumatologist - December 3, 2018 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Psoriasis psoriatic arthritis type II diabetes Source Type: research

Post-Traumatic Osteoarthritis: Managing OA That Develops After Joint Injuries & Reconstructive Surgery
CHICAGO—Joint trauma is one of many potential drivers of osteoarthritis disease activity and structural progression. In Post-Traumatic OA: Pathogenesis, Clinical Evolution and Management, a session at the 2018 ACR/ARHP Annual Meeting, experts discussed the effects of sports and other injuries on even young patients’ joints. Post-traumatic osteoarthritis (OA) may account for 12% of hip, knee... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 29, 2018 Category: Rheumatology Authors: Susan Bernstein Tags: American College of Rheumatology Conditions Meeting Reports Osteoarthritis 2018 ACR/ARHP Annual Meeting Source Type: research

Nonsurgical Therapies for Knee OA Pain: From Medications to Bracing to Exercise, What Works & What Doesn ’t
CHICAGO—Many nonsurgical therapies are available for knee osteoarthritis pain, but they vary greatly in effectiveness. “How should I proceed and figure out what to do with our patients?” asked David T. Felson, MD, MPH, professor of medicine at Boston University School of Medicine, during OA Management Without Surgery in 2018, a session at the 2018... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 29, 2018 Category: Rheumatology Authors: Susan Bernstein Tags: American College of Rheumatology Conditions Meeting Reports Osteoarthritis 2018 ACR/ARHP Annual Meeting Source Type: research

Emerging Treatments for OA: New Therapies Target Joint Pain, Not Just Structural Damage
CHICAGO—Are effective treatments for osteoarthritis (OA) on the horizon? In Emerging Treatments for Osteoarthritis at the 2018 ACR/ARHP Annual Meeting, experts discussed potential therapies to address OA structural progression, pain and inflammation. With an aging population and rising obesity rates, “we can expect the prevalence of osteoarthritis will only increase,” said Anne-Marie Malfait, MD, PhD,... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 29, 2018 Category: Rheumatology Authors: Susan Bernstein Tags: American College of Rheumatology Conditions Meeting Reports Osteoarthritis 2018 ACR/ARHP Annual Meeting Pain Source Type: research

Managing Multiple Rheumatic Diseases: How One Patient Copes with Her Disabilities & Advocates for Others
By the time Kelly Conway was diagnosed with rheumatoid arthritis (RA) in 2007, she had already been living with symptoms of the disease for 23 years. Her first symptom appeared when she was 14—knee pain that was incorrectly diagnosed as tendonitis. Over the years, she has experienced fevers and sore joints. She was diagnosed with... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 28, 2018 Category: Rheumatology Authors: Natasha Yetman Tags: Conditions Source Type: research

Silent Cardiac Impairment in SLE
Drug-naive, new-onset SLE patients, even those with inactive disease, are likely to have silent cardiac impairment, according to a new study by Guo et al. Cardiac involvement is the leading cause of death in patients with lupus, and the estimates of cardiac impairment in SLE range from 31–70%. Cardiac impairment can remain unrecognized until after autopsy. These researchers investigated the use of cardiac MRI to explore early warning signs of silent cardiac involvement in SLE and determine treatment timing... (Source: The Rheumatologist)
Source: The Rheumatologist - November 27, 2018 Category: Rheumatology Authors: Arthritis & Rheumatology Tags: Conditions SLE (Lupus) Cardiac Magnetic resonance imaging (MRI) systemic lupus erythematosus (SLE) Source Type: research

Rituximab Receives Label Update for ANCA-Associated Vasculitis
The FDA has approved an update for rituximab’s label, which will include safety and efficacy information for treating ANCA-associated vasculitis... (Source: The Rheumatologist)
Source: The Rheumatologist - November 26, 2018 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates FDA GPA granulomatosis with polyangiitis microscopic polyangiitis (MPA) U.S. Food and Drug Administration (FDA) Source Type: research

Long-Term Canakinumab Treatment Has Favorable Effect on Systemic Features & Joint Health for sJIA
During a five-year trial of canakinumab, patients with systemic juvenile idiopathic arthritis taking canakinumab showed progress toward clinical remission and glucocorticoid tapering... (Source: The Rheumatologist)
Source: The Rheumatologist - November 21, 2018 Category: Rheumatology Authors: Carina Stanton Tags: Conditions canakinumab juvenile idiopathic arthritis (JIA) Pediatric sJIA Source Type: research

Cerebral Blood Flow Variability May Provide Insights into Fibromyalgia
Recent research demonstrated that fibromyalgia patients have lower cerebral blood flow velocity variability than healthy controls, which may reflect impaired coordination of cerebral regulatory systems. This analysis may be a promising tool for characterizing fibromyalgia pathology and understanding health-related quality of life... (Source: The Rheumatologist)
Source: The Rheumatologist - November 20, 2018 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions cerebral blood flow velocity Fibromyalgia Pain Source Type: research

Psoriatic Arthritis Patients Show Long-Term, Sustained Improvement with Secukinumab
In a four-year study, patients with active psoriatic arthritis (PsA) experienced sustained improvement in PsA signs and symptoms on secukinumab... (Source: The Rheumatologist)
Source: The Rheumatologist - November 20, 2018 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Conditions psoriatic arthritis secukinumab Source Type: research

Pfizer Plans to Increase U.S. Drug Prices in January
NEW YORK (Reuters)—Pfizer Inc. said on Friday that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous price increases this summer under pressure from President Donald Trump. The company said in a statement that the increases would be on around 10% of its drugs. Pfizer said... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: Reuters Staff Tags: Drug Updates Pharma Co. News drug costs drug prices drug pricing Pfizer Inc. Source Type: research

Up to Date with the HIPAA Privacy Rule
Throughout a patient’s lifetime, providers are entrusted with their most intimate and personal information, which they expect to be kept private and confidential. Unfortunately, the healthcare system can face serious implications if any part of a patient’s privacy or information is breached. Under the Health Information Portability & Accountability Act (HIPAA) and state laws healthcare... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: From the College Tags: From the College HIPAA privacy Source Type: research

Coding Corner Answers: A Drug Administration Quiz
Take the challenge. C—This claim cannot be coded without querying the infusion nurse and physician. There must be documentation of the patient’s weight to document the correct dosage of the medication to be given to the patient. Also the start time and the completion time of the infusion must be documented to know which drug... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College adalimumab Billing & Coding denosumab ibandronate sodium infliximab Source Type: research

Coding Corner Questions: A Drug Administration Quiz
A 70–year-old female patient with rheumatoid arthritis affecting multiple joints who is rheumatoid-factor positive but without organ or system failure returns for her third infliximab infusion. She is scheduled to receive 500 mg of the drug. How should this encounter be coded? 96413, 96415, J1745 x 50; ICD 10: M05.79 96413, 96415, J1745 x 50;... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College adalimumab Billing & Coding denosumab ibandronate sodium infliximab Source Type: research

New ACR COIN Project Connects Volunteers to Patients in Greatest Need
Improving access to rheumatology care for underserved patient populations is a priority for the ACR, and the subject of a major position statement by the Committee on Rheumatologic Care (CORC) in 2017. According to the ACR’s 2015 Workforce Study, the existing shortage of rheumatologists and rheumatology health professionals is expected to worsen in the next... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: Susan Bernstein Tags: From the College COIN Collaboration Initiatives Volunteers to Expand Rheumatology Access (VERA) Source Type: research

2018 Annual Meeting Attendees Receive Free ACR Beyond Subscription
All 2018 ACR/ARHP Annual Meeting attendees received a complimentary, one-year ACR Beyond Streaming subscription. Recipients have access to all of the recorded sessions from the Annual Meeting, as well as more than 500 sessions from past meetings. In addition, they have the opportunity to view recorded sessions from upcoming 2019 educational meetings, including the Winter... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: From the College Tags: From the College 2018 ACR/ARHP Annual Meeting video streaming Source Type: research

Rheumatology Research Foundation Launches $75M Fundraising Push
The Rheumatology Research Foundation has embarked on its third and most ambitious fundraising campaign, with a goal of raising $75 million. The Leading Boldly: Transforming Rheumatology campaign will support Foundation programs to recruit the best and brightest into the field, train rheumatology health professionals at all career stages and support investigators conducting research that will... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: From the College Tags: From the College campaign Fundraising Rheumatology Research Foundation Source Type: research

Sputum Antibody Response in People at Risk for RA
Researchers say a study of individual antibody response to citrullinated and non-citrullinated proteins in sputum samples further supports the importance of the lung in early development of rheumatoid arthritis-related autoimmunity. Investigation of the fundamental mechanism that leads to antibody responses in rheumatoid arthritis is key to uncovering ways to predict and prevent the development of... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: Catherine Kolonko Tags: Conditions Research Reviews Rheumatoid Arthritis anti-citrullinated protein antibody (ACPA) sputum Source Type: research

Pediatric Lupus Outcomes: Researchers Follow Kids into Adulthood
Arecent study published in the May issue of Arthritis Care & Research may be the first to examine the long-term outcomes of childhood-onset lupus, otherwise known as pediatric systemic lupus erythematosus (SLE), a chronic, multisystem autoimmune disease with a highly variable clinical course. Previous studies examined cross-sectional views of damage accrued. According to the Childhood... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: Linda Childers Tags: Conditions Research Reviews SLE (Lupus) Flares SLICC/ACR Damage Index Source Type: research

The Burden of Rheumatic Diseases Among Indigenous People in Latin America Is Disproportionate
Indigenous communities in Latin America lack good healthcare—and often lack any healthcare—for musculoskeletal and rheumatic diseases.1 Global health initiatives tend to focus on infectious disease, despite the increasing rate of chronic diseases. In a survey of 6,155 individuals from eight indigenous communities, conducted by a team of Latin American investigators, the prevalence of these conditions... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: David C. Holzman Tags: Conditions Research Reviews Access to care Prevalence Socioeconomic Impact Source Type: research

Canakinumab Reduces Risk for Gout Flares, But Not Serum Uric Acid Levels
An exploratory analysis of a canakinumab clinical trial has shown the interleukin 1β inhibitor may significantly reduce patients’ risk for gout flares. During the study, patients using canakinumab experienced this decreased risk, but the treatment did not change serum uric acid levels... (Source: The Rheumatologist)
Source: The Rheumatologist - November 19, 2018 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Crystal Arthritis anti-interleukin canakinumab flare Gout Source Type: research

Impact of Medicare Billing Changes Varies by Specialty
NEW YORK (Reuters Health)—The proposed collapsing of payment amounts for levels 2 to 5 evaluation and management (E/M) services by the U.S. Centers for Medicare and Medicaid Services (CMS) would have different financial impacts on different specialties, researchers report. “Specialists that tend to have more complicated and/or longer visits would lose money, and specialists that... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 15, 2018 Category: Rheumatology Authors: Will Boggs MD Tags: Practice Management evaluation and management (E/M) services Medicare billing changes U.S. Centers for Medicare and Medicaid Services (CMS) Source Type: research

Walmart, Home Depot Adopt Health Insurer Tactic in Drug Copay Battle
NEW YORK (Reuters)—Walmart and Home Depot, two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications. Large U.S. companies have started tightly managing how employees and their family members use these popular discount, or copay, cards... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 15, 2018 Category: Rheumatology Authors: Caroline Humer and Michael Erman Tags: Pharma Co. News copay maximizers copay accumulators copay cards CVS Health discount cards Express Scripts Holding Co health insurance strategy Home Depot Walmart Source Type: research

New RheumPAC Chair Zachary Wallace, MD, MSc, Promotes a Louder Voice for Rheumatology
A patient Zachary Wallace, MD, MSc, met during his third year of medical school at Georgetown University helped lead him to his passion for rheumatology. He was completing a clinical rotation in medicine, and the experience made rheumatologic disease tangible for him. “She had lupus, and I became interested in her case,” he says. Later,... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 14, 2018 Category: Rheumatology Authors: Kelly Tyrrell Tags: Profiles RheumPAC chair Zachary Wallace Source Type: research

ACR Honors U.S. Sen. Susan Collins
Sen. Susan Collins (R-Maine) is the recipient of the ACR’s 2018 Award for Public Leadership in Rheumatology. Sen. Collins has championed several pieces of legislation that support rheumatologists and rheumatology patients, and she has taken part in multiple efforts to address ongoing concerns in rheumatology. “Sen. Collins has consistently worked both sides of the aisle... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 14, 2018 Category: Rheumatology Authors: Kelly Tyrrell Tags: Profiles 2018 Award for Public Leadership in Rheumatology Patient Right to Know Drug Prices Act rheumatology champion Sen. Susan Collins Source Type: research

ACR Honors Sen. Susan Collins
Sen. Susan Collins (R-Maine) is the recipient of the ACR’s 2018 Award for Public Leadership in Rheumatology. Sen. Collins has championed several pieces of legislation that support rheumatologists and rheumatology patients, and she has taken part in multiple efforts to address ongoing concerns in rheumatology. “Sen. Collins has consistently worked both sides of the aisle... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 14, 2018 Category: Rheumatology Authors: Kelly Tyrrell Tags: Profiles 2018 Award for Public Leadership in Rheumatology Patient Right to Know Drug Prices Act rheumatology champion Sen. Susan Collins Source Type: research

Beth Jonas: Making a Difference in Training & Workforce Support
Early in her medical school career, Beth Jonas, MD, FACR, was fascinated by the multi-system and chronic nature of rheumatic diseases. The field of rheumatology offered her the chance to make long-term connections with the patients she cares for, and she says her early instincts have led her to a career that has not disappointed.... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 14, 2018 Category: Rheumatology Authors: Carina Stanton Tags: Profiles Beth Jonas Committee on Rheumatology Training and Workforce Issues Source Type: research

What the Election Means for Rheumatology
The 2018 U.S. midterm elections mobilized American voters, bringing more than 100 million people to the polls.1 It also brought the House of Representatives under the control of Democrats, while Republicans maintained control of the Senate, splitting the legislative branch between two parties. As the 116th Congress prepares to convene in January 2019, the ACR’s... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 14, 2018 Category: Rheumatology Authors: Cindy Devone-Pacheco Tags: Legislation & Advocacy 2018 U.S. midterm election Source Type: research

Quality Payment Program Year 3 Reporting Changes: What You Need to Know
The Centers for Medicare & Medicaid Services (CMS) released the final rule for the Quality Payment Program (QPP) year 3 (CY 2019) on Nov. 1, 2018. Below, we have compiled a list of key changes to ensure MIPS-eligible clinicians are accurately reporting for CY 2019: New MIPS-eligible clinician types: Physical therapist, occupational therapist, qualified speech-language... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 14, 2018 Category: Rheumatology Authors: From the College Tags: From the College CMS final rule MIPS reporting Quality Payment Program (QPP) year 3 (CY 2019) Source Type: research

FDA Approves Opioid Treatment
The FDA has approved the use of sublingual sufentanil (Dsuvia) to treat acute pain in adults in a medically supervised setting... (Source: The Rheumatologist)
Source: The Rheumatologist - November 13, 2018 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Analgesics Drug Updates drug approvals FDA opioid Pain sublingual sufentanil U.S. Food and Drug Administration (FDA) Source Type: research

A Balancing Act: Tips to Ensure Optimal Screening & Treatment for Osteoporosis
Patients with rheumatic diseases may be undertreated for osteoporosis. To decrease fracture risk for at-risk patients, rheumatologists can engage patients in shared decision making with regular screening and education about treatment options... (Source: The Rheumatologist)
Source: The Rheumatologist - November 12, 2018 Category: Rheumatology Authors: Carina Stanton Tags: Conditions bone fracture fracture risk Osteoporosis patient care Source Type: research

Ustekinumab May Be Effective for Lupus
New research underscores the possibility that interleukin (IL) 12, IL-23 or both play roles in the immunopathology of SLE. In the study, when added to standard-of-care treatment for active SLE, ustekinumab demonstrated better efficacy than placebo and had a safety profile consistent with that of ustekinumab therapy in other diseases... (Source: The Rheumatologist)
Source: The Rheumatologist - November 12, 2018 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions SLE (Lupus) systemic lupus erythematosus (SLE) ustekinumab Source Type: research

Final 2019 Physician Reimbursement Rule Released by CMS Includes Victories for Rheumatology
Yesterday the Centers for Medicare and Medicaid Services (CMS) released the CY 2019 Medicare physician fee schedule rule, and it included several victories for rheumatology. Upon initial review, it appears the CMS has taken into account the concerns expressed by the ACR and other stakeholders about collapsing the evaluation and management (E/M) service codes. Included... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 7, 2018 Category: Rheumatology Authors: From the College Tags: American College of Rheumatology Legislation & Advocacy Professional Topics 2019 Physician Reimbursement Rule Source Type: research

5-Year Data on Secukinumab in AS; Oliceridine Not Recommended for FDA Approval
In a long-term study, secukinumab proved safe and effective for treating ankylosing spondylitis... (Source: The Rheumatologist)
Source: The Rheumatologist - November 7, 2018 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Analgesics Biologics & Biosimilars Drug Updates Ankylosing spondylitis (AS) FDA oliceridine Pain secukinumab U.S. Food and Drug Administration (FDA) Source Type: research

Ixekizumab Improves Outcomes of Ankylosing Spondylitis
NEW YORK (Reuters Health)—Ixekizumab improves signs and symptoms in patients with radiographic axial spondyloarthritis (ankylosing spondylitis), according to results from the COAST-W study. “Ankylosing spondylitis is a chronic and debilitating disease, and I have a large number of patients who have failed TNF inhibitors,” says Dr. Atul Deodhar from Oregon Health and Science University, Portland.... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 6, 2018 Category: Rheumatology Authors: Will Boggs, MD Tags: Biologics & Biosimilars Drug Updates Ankylosing spondylitis (AS) ixekizumab TNF inhibitor Source Type: research

Is More Better? Weight Loss Analysis in Older Patients with Knee OA
Obesity is a modifiable risk factor for many patients with knee osteoarthritis (OA), and the National Institutes of Health recommend an initial weight loss goal of 10%. But how does losing more weight affect knee OA patients? In a new study, researchers compared the outcomes of knee OA patients who lost more and less than the recommended 10% of their baseline weight, finding significant improvement in health-related quality of life and reduction in pain for patients who lost twice what’s recommended... (Source: The Rheumatologist)
Source: The Rheumatologist - November 6, 2018 Category: Rheumatology Authors: Arthritis Care & Research Tags: Conditions Osteoarthritis Arthritis Care & Research knee Knee Osteoarthritis (OA) Obesity weight loss Source Type: research

2018 MIPS Reporting via RISE: Are You Ready?
It’s time to prepare for 2018 MIPS reporting via the Rheumatology Informatics System for Effectiveness (RISE) registry, and the ACR is here to help. To ensure you’re ready to submit your data to the CMS, RISE users should take the following steps: Complete the survey to notify the ACR of your intent to report via... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 5, 2018 Category: Rheumatology Authors: From the College Tags: From the College Technology 2018 MIPS reporting Rheumatology Informatics System for Effectiveness (RISE) clinical data registry Source Type: research

Protect Your Practice: Action Update From the ACR ’s Insurance Subcommittee
Both private and academic rheumatology practices face payer challenges that put the health of their patients and their practices at risk. To make sure the rheumatologist perspective is heard by payers, “the ACR’s Insurance Subcommittee (ISC) serves as the interface between payers and our members and ACR colleagues,” explains Sean Fahey, MD, a rheumatologist in... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 5, 2018 Category: Rheumatology Authors: Carina Stanton Tags: American College of Rheumatology Legislation & Advocacy ACR Insurance Subcommittee (ISC) downcoding modifier 25 United Healthcare (UHC) Source Type: research

RheumPAC Champions Recognized
Election Day 2018 has come and gone, and a new class of legislators will be joining the ranks of Congress in January. RheumPAC is the most important tool we have to establish relationships with our new legislators and this year, our ACR volunteer leaders stepped up and matched all donations to RheumPAC leading up to... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - November 5, 2018 Category: Rheumatology Authors: From the College Tags: American College of Rheumatology From the College Legislation & Advocacy RheumPAC RheumPAC match campaign Source Type: research